Human Molecular Genetics · 2015 · 54 citations · 50 references
MedicineGeneticsMolecular GeneticsBone MetabolismHuman GeneticsMedical GeneticsBone DisordersBone Metabolism DisordersDown SyndromeGenetic DisordersGenetic SyndromesSkeletal DevelopmentAppendicular AnatomyAutosomal TrisomyBone Mineral DensityBone Mineral Density DeclineBone MorphometryCongenital Skeletal DisordersSkeletal AbnormalitiesTherapeutic Modulation
Trisomy 21 causes skeletal alterations in individuals with Down syndrome (DS), but the causative trisomic gene and a therapeutic approach to rescue these abnormalities are unknown. Individuals with DS display skeletal alterations including reduced bone mineral density, modified bone structure and distinctive facial features. Due to peripheral skeletal anomalies and extended longevity, individuals with DS are increasingly more susceptible to bone fractures. Understanding the genetic and developmental origin of DS skeletal abnormalities would facilitate the development of therapies to rescue these and other deficiencies associated with DS. DYRK1A is found in three copies in individuals with DS and Ts65Dn DS mice and has been hypothesized to be involved in many Trisomy 21 phenotypes including skeletal abnormalities. Return of Dyrk1a copy number to normal levels in Ts65Dn mice rescued the appendicular bone abnormalities, suggesting that appropriate levels of DYRK1A expression are critical for the development and maintenance of the DS appendicular skeleton. Therapy using the DYRK1A inhibitor epigallocatechin-3-gallate improved Ts65Dn skeletal phenotypes. These outcomes suggest that the osteopenic phenotype associated with DS may be rescued postnatally by targeting trisomic Dyrk1a.
50
Samantha E. Parker, Mark A. Canfield, Russel Rickard et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2010 · 1.9K citations
Public Health, Maternal Health, Population Health Sciences +16
The specificities of protein kinase inhibitors: an update
Jenny Bain, Hilary McLauchlan, Matthew Elliott et al. · Biochemical Journal · 2003 · 1.4K citations · Full text
A mouse model for Down syndrome exhibits learning and behaviour deficits
Roger H. Reeves, Nicholas G. Irving, Timothy H. Moran et al. · Nature Genetics · 1995 · 914 citations
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron, Monte M. Winslow, Alberto Polleri et al. · Nature · 2006 · 698 citations